Connor, Clark & Lunn Investment Management (CC&L)’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-32,119
Closed -$309K 844
2013
Q4
$309K Buy
+32,119
New +$309K ﹤0.01% 594